Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Risk Model–Based Lung Cancer Screening

Annals of Internal Medicine(2023)10.7326/m22-2216Source: DataRank Database

Risk Model–Based Lung Cancer Screening is a research paper published in Annals of Internal Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 62 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access62 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 10.69)OA: greenTopics (26)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Pianpian Cao ORCID,Koen de Nijs ORCID,Mehrad Bastani ORCID,Vidit Munshi ORCID,Mehdi Hemmati ORCID

Live enrichment

PubMed:36745885 PMC:PMC11025620 OpenAlex:https://openalex.org/W4319302341

NCI NIH HHS

Grant: U01 CA253858

NCI NIH HHS

Grant: U01 CA199284

FWCI

10.69

Citation Percentile

1.0%

Influential Citations

Citation Trend

2023

2024

2025

2026

green

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11025620/pdf/nihms-1974223.pdf

repositoryhttp://www.scopus.com/inward/record.url?scp=85150752272&partnerID=8YFLogxK

journalhttps://doi.org/10.7326/m22-2216

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36745885

Fields of Study

Lung Cancer Diagnosis and TreatmentLung Cancer Treatments and MutationsDelphi Technique in ResearchMedicine

MeSH Terms

Cost-Effectiveness AnalysisAged, 80 and overCost-Benefit AnalysisHumansLungLung NeoplasmsMass ScreeningMiddle AgedQuality-Adjusted Life YearsEarly Detection of Cancer

Keywords

MedicineLung cancer screeningCost effectivenessQuality-adjusted life yearLung cancerCohortRisk assessmentCohort studyCancer screeningCancerInternal medicineRisk analysis (engineering)

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Risk-based lung cancer screening in heavy smokers: a benefit–harm and cost-effectiveness modeling study

10.6084/m9.figshare.25242243.v1figshare

Additional file 1 of Risk-based lung cancer screening in heavy smokers: a benefit–harm and cost-effectiveness modeling study

10.6084/m9.figshare.25242243figshare

Additional file 2 of Risk-based lung cancer screening in heavy smokers: a benefit–harm and cost-effectiveness modeling study

10.6084/m9.figshare.25242416.v1figshare

Additional file 2 of Risk-based lung cancer screening in heavy smokers: a benefit–harm and cost-effectiveness modeling study

10.6084/m9.figshare.25242416figshare